Short Summary
Apple’s IPR resulted in the Board finding all six challenged claims of Omni MedSci’s ’299 patent unpatentable as obvious over a combination of prior‑art references covering wearable optical sensing.
Detailed Summary
In IPR2025-01253, Apple challenged claims 7 and 10–14 of Omni MedSci’s U.S. Patent No. 12,193,790 covering a wearable physiological measurement system. The Board instituted the review on all grounds raised and, after extensive analysis, concluded that the asserted claims were obvious under 35 U.S.C. §103. The decision relied on the combination of prior‑art references Lisogurski, Carlson, Mannheimer, and Park, finding that each limitation—including the pulse‑rate increase for signal‑to‑noise improvement—was taught or suggested. The Board accepted Petitioner’s evidence, expert testimony, and admissions by the Patent Owner, and ordered all challenged claims unpatentable.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in SAMSUNG ELECTRONICS CO., LTD. et al. vs OMNI MEDSCI, INC. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Samsung Electronics Co., Ltd. et al.vsWilus Institute of Standards and Technology Inc.
The PTAB denied Samsung's request for Director Review of the institution decision in IPR2025-00935, leaving the institution standing.
Samsung Electronics Co. Ltd. et al.vsMaxell, Ltd.
The USPTO Board denied institution of IPR2025-01313 after a merits review, finding the petitioner failed to show a reasonable likelihood of prevailing.
Amazon.com, Inc. et al.vsNL Giken Inc.
Amazon has filed an IPR petition seeking cancellation of all 13 claims of NL Giken’s ’592 patent, arguing obviousness over Walker and Chang references and opposing discretionary denial.
LG Electronics, Inc. et al.vsMaxell, Ltd.
LG Electronics and Maxell settled their dispute over U.S. Patent 7,421,188 B2. The parties filed a joint motion to terminate the IPR, and the Board granted the termination before instituting a trial.
FreightCar America, Inc.vsNational Steel Car Limited
FreightCar America has filed an IPR petition seeking cancellation of all 15 claims of National Steel Car’s hopper‑car patent, asserting that the invention was disclosed in early rail‑car literature and patents dating back to 1919.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.